Почетна › Dijabetes tipa 2 › Ilinois
Kliničke studije za Dijabetes tipa 2 u državi Ilinois
32 studija za Dijabetes tipa 2 traži učesnike na lokacijama u državi Ilinois.
Gradovi u državi Ilinois
Zvanični tekst studije (na engleskom)
A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
- Evanston Premier Healthcare Research LLC, Skokie
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 13. 11. 2026. · NCT07754461EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Cedar Crosse Research Center, Chicago
- Accellacare of Duly - Lombard, Lombard
- Accellacare of Duly, Oak Lawn
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT07064473A Study to Investigate Safety, Tolerability, PK, and PD of AZD4248 in Healthy Participants, Participants With CKD and Type 2 Diabetes, Assess Home Measurements of Creatinine in a Non-Interventional Cohort, and Assess the Effect of AZD4248 on the PK of Midazolam and Metformin in Healthy Participants
- Research Site, Chicago
Тражи се учесникФаза 1Здраве особе су добродошле
Узраст од 18 до 75 · Оба пола · Ажурирано 12. 11. 2026. · NCT07024823A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
- Research Site, Champaign
- Research Site, Chicago
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 9. 11. 2026. · NCT07776509A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
- Central Illinois Diabetes and Clinical Research, Springfield
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 9. 11. 2026. · NCT07351058A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
- Cedar Crosse Research Center, Chicago
- Northwestern University, Chicago
- Endeavor Health - Family Medicine Administration, Evanston
- и још 1
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT07595549A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
- NorthShore University Health System, Skokie
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07282600A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
- Accellacare - DuPage, Lombard
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT07783802A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
- Research Site, Chicago
- Research Site, Skokie
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 30. 10. 2026. · NCT07662109A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
- Research Site, Chicago
- Research Site, Melrose Park
- Research Site, Oak Brook
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 28. 10. 2026. · NCT07784270Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
- Research by Design, LLC - Internal Medicine, Chicago
Тражи се учесникФаза 2
Узраст од 18 до 80 · Оба пола · Ажурирано 27. 10. 2026. · NCT07271186A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
- Research Site, Melrose Park
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 22. 10. 2026. · NCT07662213Achieving Routine Intervention and Screening for Emotional Health
- University of Chicago, Chicago
Тражи се учесник
Узраст 18 и старији · Оба пола · Ажурирано 21. 10. 2026. · NCT06887049Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus
- Charter Research - Chicago, Chicago
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 19. 10. 2026. · NCT07527650A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes
- SIU Medicine, Springfield
Тражи се учесникФаза 3
Узраст од 10 до 18 · Оба пола · Ажурирано 19. 10. 2026. · NCT07282613Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
- Chicago Clinical Research Institute, Chicago
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 6. 10. 2026. · NCT07296484Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
- Endeavor Health, Skokie
Тражи се учесникФаза 3
Узраст од 18 до 99 · Оба пола · Ажурирано 5. 10. 2026. · NCT07684144Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema
- Endeavor Health, Skokie
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 30. 9. 2026. · NCT07817251A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
- Northwestern University, Chicago
- Northshore University Health System, Glenview
Тражи се учесникЗдраве особе су добродошле
Узраст 55 и старији · Оба пола · Ажурирано 28. 9. 2026. · NCT06112418A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
- AURORA-2 Clinical Site, Schaumburg
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 16. 9. 2026. · NCT07743450A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes
- Cedar-Crosse Research Center, Chicago
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 11. 9. 2026. · NCT07415954A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
- Research Site, Chicago
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 2. 9. 2026. · NCT07662135AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
- Elevate Clinical Research, Gurnee
- Chicago Medical Research LLC, Hazel Crest
- Genesis Orthopedics & Sports Medicine, Oak Brook
- и још 1
Тражи се учесникФаза 3
Узраст 45 и старији · Оба пола · Ажурирано 1. 9. 2026. · NCT07797335A Study to Identify and Characterize Patients With Type 2 Diabetes Mellitus for Possible Participation in Ongoing or Future Type 2 Diabetes Mellitus Clinical Studies
- Research Site, Melrose Park
Тражи се учесникОпсервациона студија
Узраст 18 и старији · Оба пола · Ажурирано 25. 8. 2026. · NCT07606066A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
- University of Illinois at Chicago, Chicago
Тражи се учесникФаза 3
Узраст од 10 до 17 · Оба пола · Ажурирано 7. 8. 2026. · NCT06739122Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes
- Northwestern University, Chicago
Тражи се учесник
Узраст од 18 до 75 · Оба пола · Ажурирано 3. 8. 2026. · NCT07521475Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System
- Northwestern University, Chicago
Тражи се учесник
Узраст од 14 до 75 · Оба пола · Ажурирано 3. 8. 2026. · NCT07579702Mathematical Modeling of Blood Sugar and Hormone Responses in Insulin-Dependent Type 2 Diabetes
- Illinois Institute of Technology, Chicago
Тражи се учесникОпсервациона студија
Узраст од 18 до 65 · Оба пола · Ажурирано 16. 6. 2026. · NCT07650682Exercise and Protein Efficiency in T2D
- Freer Hall - University of Illinois, Urbana
Тражи се учесникЗдраве особе су добродошле
Узраст 65 и старији · Оба пола · Ажурирано 29. 4. 2026. · NCT07477067Enhancing Diabetes Care: Exposome &Amp; Sensors
- University of Illinois - Chicago, Chicago
- University of Illinois College of Nursing, Chicago
Тражи се учесникОпсервациона студија
Узраст од 18 до 65 · Оба пола · Ажурирано 25. 5. 2025. · NCT06989008My ESSENCE - A Research Study on Mindfulness for African-Americans With Type 2 Diabetes
- University of Illinois at Chicago, Chicago
Тражи се учесникЗдраве особе су добродошле
Узраст од 21 до 75 · Оба пола · Ажурирано 5. 3. 2025. · NCT05208164RCT Glargine vs NPH for Treatment of DM in Pregnancy
- Loyola University Medical Center, Maywood
Тражи се учесникФаза 3
Узраст 18 и старији · Жене · Ажурирано 1. 10. 2024. · NCT06619301Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.